We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

79 hedge funds and large institutions have $102M invested in Vicarious Surgical in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more call options, than puts

Call options by funds: $218K | Put options by funds: $74K

17% more capital invested

Capital invested by funds: $87.1M → $102M (+$14.8M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

0.05% more ownership

Funds ownership: 1.4%1.45% (+0.05%)

0% more funds holding

Funds holding: 7979 (0)

0% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 24

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
79
Holders Change
Holders Change %
0%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
11
Increased
24
Reduced
24
Closed
10
Calls
$218K
Puts
$74K
Net Calls
+$144K
Net Calls Change
+$523K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$143K +$47.1K +606 +40%
SO
27
STRS Ohio
Ohio
$142K
Millennium Management
28
Millennium Management
New York
$131K -$648K -8,328 -81%
WAM
29
Werlinich Asset Management
Connecticut
$112K -$1.79K -23 -1%
Brown Advisory
30
Brown Advisory
Maryland
$97.3K
JP Morgan Chase
31
JP Morgan Chase
New York
$96K +$29.7K +382 +37%
Deutsche Bank
32
Deutsche Bank
Germany
$81.3K +$29.4K +378 +46%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$78.8K +$90K +1,157 New
MIM
34
MetLife Investment Management
New Jersey
$75.5K +$45.9K +590 +114%
BCM
35
Brainard Capital Management
Texas
$75.4K
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$67.3K +$75.5K +971 New
Invesco
37
Invesco
Georgia
$67.1K +$2.8K +36 +4%
Barclays
38
Barclays
United Kingdom
$63.8K +$34.3K +441 +89%
RP
39
Riverwater Partners
Wisconsin
$63.2K
AIG
40
American International Group
New York
$60.6K +$1.4K +18 +2%
Bank of America
41
Bank of America
North Carolina
$58.3K -$98.6K -1,268 -60%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$57K -$11.7K -150 -15%
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$55K
XT
44
XTX Topco
Cayman Islands
$54.2K +$61.9K +796 New
VOYA Investment Management
45
VOYA Investment Management
Georgia
$53.8K
SG Americas Securities
46
SG Americas Securities
New York
$50K +$57.1K +735 New
Squarepoint
47
Squarepoint
New York
$49.5K -$7.23K -93 -11%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$46.6K -$3.89K -50 -7%
KAS
49
Kestra Advisory Services
Texas
$37.3K +$1.01K +13 +2%
NW
50
NewEdge Wealth
Pennsylvania
$32.5K

RBOT Hedge Fund Activity: Q1 2023 in Review

79 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q1 2023, worth a combined $102M — up 17% from $87.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RBOT positions and 10 closed out — a net gain of 1 holder — while 24 added to existing stakes and 24 trimmed.

The largest buyer was VK Services, adding an estimated $6.13M. The largest seller was Jane Street, cutting an estimated $1.15M.

  • 79 institutional investors held Vicarious Surgical (RBOT) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $102M of Vicarious Surgical stock for Q1 2023, up 17% quarter-over-quarter.
  • 11 funds opened new Vicarious Surgical positions in Q1 2023 and 10 closed out, a net change of +1 holder.
  • The largest Vicarious Surgical buyer in Q1 2023 was VK Services, an estimated $6.13M added.
  • The largest Vicarious Surgical seller in Q1 2023 was Jane Street, an estimated $1.15M sold.

Based on aggregated 13F filings for Q1 2023.